The Gabelli Healthcare & Wellness Trust (NYSE:GRX) Sees Large Decrease in Short Interest

The Gabelli Healthcare & Wellness Trust (NYSE:GRX) was the target of a significant decline in short interest in the month of August. As of August 31st, there was short interest totaling 4,191 shares, a decline of 35.4% from the August 15th total of 6,492 shares. Based on an average trading volume of 32,325 shares, the days-to-cover ratio is presently 0.1 days.

Insider Transactions at The Gabelli Healthcare & Wellness Trust

In other news, major shareholder Saba Capital Management, L.P. purchased 24,102 shares of the business’s stock in a transaction that occurred on Wednesday, August 19th. The stock was purchased at an average cost of $10.13 per share, with a total value of $244,153.26. Following the completion of the acquisition, the insider directly owned 2,143,706 shares of the company’s stock, valued at approximately $21,715,741.78. This trade represents a 1.14% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders have bought 37,832 shares of company stock worth $382,333 over the last three months.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Sit Investment Associates Inc. boosted its position in shares of The Gabelli Healthcare & Wellness Trust by 23.7% during the 4th quarter. Sit Investment Associates Inc. now owns 1,031,350 shares of the investment management company’s stock worth $9,932,000 after purchasing an additional 197,594 shares in the last quarter. Gamco Investors INC. ET AL increased its holdings in shares of The Gabelli Healthcare & Wellness Trust by 1.1% in the 1st quarter. Gamco Investors INC. ET AL now owns 346,026 shares of the investment management company’s stock valued at $3,132,000 after purchasing an additional 3,800 shares in the last quarter. Blue Bell Private Wealth Management LLC lifted its stake in shares of The Gabelli Healthcare & Wellness Trust by 5.3% in the fourth quarter. Blue Bell Private Wealth Management LLC now owns 292,672 shares of the investment management company’s stock valued at $2,818,000 after purchasing an additional 14,814 shares during the period. Aviance Capital Partners LLC lifted its stake in shares of The Gabelli Healthcare & Wellness Trust by 2.1% in the first quarter. Aviance Capital Partners LLC now owns 171,325 shares of the investment management company’s stock valued at $1,550,000 after purchasing an additional 3,482 shares during the period. Finally, Uhlmann Price Securities LLC boosted its holdings in The Gabelli Healthcare & Wellness Trust by 22.0% during the first quarter. Uhlmann Price Securities LLC now owns 61,590 shares of the investment management company’s stock worth $557,000 after buying an additional 11,088 shares in the last quarter.

The Gabelli Healthcare & Wellness Trust Trading Up 0.2%

NYSE GRX opened at $9.68 on Friday. The business’s 50 day moving average is $9.83 and its two-hundred day moving average is $9.43. The Gabelli Healthcare & Wellness Trust has a 12-month low of $8.80 and a 12-month high of $10.20.

The Gabelli Healthcare & Wellness Trust Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Wednesday, September 16th will be paid a $0.17 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 7.0%.

The Gabelli Healthcare & Wellness Trust Company Profile

The Gabelli Healthcare & Wellness Trust (NYSE: GRX) is a closed-end management investment company that seeks both capital appreciation and current income. The trust primarily invests in equity and equity-related securities of companies operating in the healthcare and wellness sectors. Trading on the New York Stock Exchange under the symbol GRX, the fund provides investors with exposure to growth opportunities in healthcare through its closed-end structure.

The trust’s portfolio is diversified across a broad range of healthcare sub-industries, including pharmaceuticals, biotechnology, medical devices, and healthcare services.